Related Experiment Video
Updated: Jan 29, 2026

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Prognostic value of late potentials in patients with congestive heart failure
M Galinier1, J P Albenque, N Afchar
1Cardiology Division, Rangueil University, Toulouse, France.
Insights
Signal-averaged ECG detection of ventricular late potentials in congestive heart failure patients did not predict overall mortality or sudden death. However, late potentials significantly identified patients at higher risk for sustained ventricular tachycardia.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Diagnostics
Background:
- Congestive heart failure (CHF) is associated with increased risk of ventricular arrhythmias.
- Ventricular late potentials (VLPs) on signal-averaged ECG (SAECG) are potential markers of arrhythmogenic substrate.
- Prognostic value of VLPs in CHF, with or without bundle branch block (BBB), requires further investigation.
Purpose of the Study:
- To determine if VLPs detected by SAECG provide prognostic information in CHF patients.
- To assess the association of VLPs with mortality, sudden cardiac death, and sustained ventricular tachycardia (SVT).
- To evaluate the utility of VLPs in risk stratification for CHF patients, including those with BBB.
Main Methods:
- Prospective study of 151 CHF patients (57 with BBB) undergoing SAECG.
- VLPs were analyzed, and patients were followed for mortality, sudden death, and VT events.
- Subgroup analyses were performed excluding patients with BBB, severe CHF, or amiodarone use.
Main Results:
- VLPs were detected in 32.5% of CHF patients, with similar incidence in patients with and without BBB.
- VLP presence was not correlated with age, NYHA class, ejection fraction, or amiodarone use.
- Total mortality, cardiac mortality, and sudden death risk were not significantly related to VLPs.
- However, patients with VLPs had a significantly higher incidence of prior and follow-up SVT (18% vs 2%, P < 0.001).
Conclusions:
- SAECG detection of VLPs in CHF patients does not reliably predict overall mortality or sudden death risk.
- VLPs improve risk stratification specifically for sustained ventricular tachycardia in CHF patients.
- The prognostic value of VLPs is limited to identifying patients at increased risk for VT events, irrespective of BBB or CHF severity.
Abstract:
To investigate whether detection of ventricular late potentials could provide prognostic information in patients with congestive heart failure with or without bundle branch block, we prospectively obtained a signal-averaged ECG from 151 patients with congestive heart failure, using specific criteria in 57 patients with bundle branch block. Late potentials were detected in 49 patients (32.5%); their incidence was not significantly different in patients without (31%; 29 patients) or with bundle branch block (35%; 20 patients). Late potentials were present in 25 of 73 patients (34%) with idiopathic dilated cardiomyopathy, in 20 of 57 patients (35%) with ischaemic cardiomyopathy and in four of 21 patients (19%) with hypertensive heart disease (ns). Age, NYHA class, ejection fraction and use of amiodarone were not statistically different among patients with or without late potentials. In contrast, patients with late potentials had more past episodes of sustained ventricular tachycardia (8.2%; four patients) than those without late potentials (1.9%; two patients). Twenty four hour ambulatory ECGs were obtained in 135 patients (89%). Non-sustained ventricular tachycardia was not correlated with the presence of late potentials found in 45 of 88 patients (51%) without late potentials and in 29 of 47 patients (62%) with late potentials (ns). The mean follow-up was 27 +/- 12 months; 51 patients died, 31 from progressive congestive heart failure and 13 suddenly; seven prospectively had sustained ventricular tachycardia. The total mortality rate, the cardiac mortality rate and sudden death risk were not significantly related to the presence of late potentials; their incidence were respectively 35% (36 patients), 32% (33 patients) and 10% (10 patients) in patients without late potentials and 31% (15 patients), 23% (11 patients) and 6% (three patients) in those without late potentials. The incidence of sustained ventricular tachycardia during follow-up was 2% (two patients) in patients without late potentials and 10% (five patients) in those with late potentials. The incidence of sustained ventricular tachycardia experienced by the patients before the study or seen during follow-up was significantly increased in the presence of late potentials: 18% (nine patients) vs 2% (two patients) in the absence of late potentials (P < 0.001). Removal from the study of data from patients with bundle branch block, patients with severe congestive heart failure (NYHA 3 or 4) or patients taking amiodarone did not alter these results. Thus, signal-averaged ECG results only improved risk stratification for sustained ventricular tachycardia in patients with congestive heart failure and failed to identify patients at high risk for sudden death.
More Related Videos
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
04:20Integration of Brain Tissue Saturation Monitoring in Cardiopulmonary Exercise Testing in Patients with Heart Failure
Published on: October 1, 2019
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Heart Failure V: Medical Management
Heart Failure II: Pathophysiology
Heart Failure I: Introduction
Pathophysiology of Heart Failure
Heart Failure Drugs: Diuretics